1,107.08 USD
↗ 5.00 (0.45%)AT CLOSE (11:59 AM EDT)
Eli Lilly & Co.
LLYNYSE • USD
1,106.78
↘ 0.30 (0.03%)
POST MARKET (AS OF 06:13 PM EDT)
Post Market
AS OF 06:13 PM EDT
1,106.78
↘ 0.30 (0.03%)
Market: OPEN
Shares of Eli Lilly & Co. (LLY) are trading at $1,106.78. Both sides of the analysis agree: technicals flash "Buy" and fundamentals confirm with a "Buy" reading. This is driven by a robust Altman Z-Score, exceptional Return on Equity (81.0%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jun 23, 2026.
Open?$1,117.00
High?$1,122.02
Low?$1,079.22
Prev. Close?$1,102.08
Volume?3.3M
Avg. Volume?3.2M
VWAP?$1,105.82
Rel. Volume?1.04x
Bid / Ask
Bid?$1,106.05 × 40
Ask?$1,108.50 × 40
Spread?$2.45
Midpoint?$1,107.28
Valuation & Ratios
Market Cap?982.8B
Shares Out?941.7M
Float?848.6M
Float %?90.1%
P/E Ratio?38.88
P/B Ratio?31.50
EPS?$28.35
Dividend?0.57%
Ex-Dividend?2026-08-14
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
979.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?83
Short Sent.?74
Piotroski F-Score?6/9Mixed
Altman Z-Score?8.96Safe
Confidence?78%Moderate
Short InterestLow
Short % of Float?1.15%Low
Short Interest?9.8M
Days to Cover?3.0
Free Float848.6M
Avg Daily Volume3.3M
Settlement Date2026-05-29
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?38.9PRICEY▾
Peers20
S&P18
P/B?31.50HIGH▾
Peers10
S&P3
P/S?13.60HIGH▾
Peers20
S&P3
P/FCF?83.1PRICEY▾
Peers10
S&P3
EV/EBITDA?28.2HIGH▾
Peers20
S&P12
EV/Sales?14.13HIGH▾
Peers20
S&P3
Returns & Efficiency
ROE?81.0%STRONG▾
Peers78
S&P97
ROA?21.7%STRONG▾
Peers90
S&P97
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$1020.9B
Fundamentals ratios updated end of day